2017
DOI: 10.4081/monaldi.2017.893
|View full text |Cite
|
Sign up to set email alerts
|

Clinical features and prognostic significance of splenic involvement in sarcoidosis

Abstract: Sarcoidosis is a systemic disease characterized by noncasefied granulomas in various organs. Incidence of splenic disease is variable and is reported to occur in 6.7 to 77 percent of the patients. Firm data establishing the clinical features and the association of splenic involvement with prognosis in sarcoidosis is scant. The aim of our study was to investigate the clinical features and the consequence of splenic involvement on the prognostic outcome of sarcoidosis patients.We evaluated the clinical and labor… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
13
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 35 publications
(13 citation statements)
references
References 16 publications
0
13
0
Order By: Relevance
“…The kinetic chain of events of granuloma formation, evolution, and distribution is the hallmark for the prognostic outcome of sarcoidosis patients. The inconsistent propensity of granuloma formation and dissemination is the foremost pathologic mechanism liable for the differences of prognosis and organ involvement between individual patients [32][33][34]. Our study reveals that the transformation of the granuloma burden is the most distinctive marker of sarcoidosis outcome while the impact grade or the intensity of infl uence of granuloma burden for each organ is uncertain.…”
Section: Discussionmentioning
confidence: 91%
“…The kinetic chain of events of granuloma formation, evolution, and distribution is the hallmark for the prognostic outcome of sarcoidosis patients. The inconsistent propensity of granuloma formation and dissemination is the foremost pathologic mechanism liable for the differences of prognosis and organ involvement between individual patients [32][33][34]. Our study reveals that the transformation of the granuloma burden is the most distinctive marker of sarcoidosis outcome while the impact grade or the intensity of infl uence of granuloma burden for each organ is uncertain.…”
Section: Discussionmentioning
confidence: 91%
“…Furthermore, the ACE levels had very good diagnostic value in patients with active sarcoidosis (sensitivity: 0.85; specificity: 0.718). There has been controversy concerning the role of serum ACE as a diagnostic and activity marker for sarcoidosis [ 11 , 15 , 21 , 22 , 29 , 30 , 31 , 32 , 33 ]. While there are several studies demonstrating that serum ACE levels are elevated in active sarcoidosis, the serum ACE levels were not significantly different between active and inactive sarcoidosis [ 11 , 15 , 29 ].…”
Section: Discussionmentioning
confidence: 99%
“…Sarcoidosis is a systemic disease characterized by noncasefied granulomas in various organs. Serum ACE was also higher in patients with diffuse splenic involvement in sarcoidosis [ 33 ]. Thus, measuring serum levels of ACE may be helpful for monitoring the disease activity of sarcoidosis.…”
Section: Discussionmentioning
confidence: 99%
“…Splenic involvement has been documented in 24 to 59% of patients with sarcoidosis undergoing routine fine needle aspiration splenic biopsies 125,126 but is usually asymptomatic. 126 Only 5 to 9% of patients with sarcoidosis have symptoms related to splenic involvement. 126 Splenic involvement can be documented by ultrasound, 127 CT, 122 or MRI scans.…”
Section: Spleenmentioning
confidence: 99%
“…126 Only 5 to 9% of patients with sarcoidosis have symptoms related to splenic involvement. 126 Splenic involvement can be documented by ultrasound, 127 CT, 122 or MRI scans. 123,126 Multiple low attenuation lesions typically range in size from 0.5 to 1.5 cm on CT or MRI, generally without enhancement 123 (►Figs.…”
Section: Spleenmentioning
confidence: 99%